瑞思迈公司在2024财年第一季度业绩释放后,股价在夜盘大涨6.04%,成为市场焦点。财报数据显示,截至9月30日的上一季度,该公司实现调整后每股收益2.20美元,超过分析师之前2.04美元的预期。公司总收入为12.2亿美元,同比增长11%,也高于华尔街11.8亿美元的预期。
公司表示,本季度收入的大幅增长主要得益于其睡眠呼吸暂停治疗设备和相关面罩产品组合需求的强劲表现。作为医疗器械行业的领导者,瑞思迈在其核心业务领域表现出了巨大的市场潜力,这也加温了投资者对其长期增长前景的信心。
分析师认为,即便未来市场环境发生变化,作为无创睡眠呼吸暂停治疗领军者,瑞思迈在该领域明年的产品销量依然会保持旺盛态势。超预期的业绩和光明的长期前景,推动了市场对瑞思迈股票的追捧,使其在夜盘出现了6.04%的大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.